|
Q4 FY2022
As of Dec 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
|
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Property, plant and equipment | ||||||
| Right-of-use assets | ||||||
| Investment properties | ||||||
| Investments in associates and joint ventures | ||||||
| Held-to-maturity securities | ||||||
| Loans | ||||||
| Term deposits | ||||||
| Statutory deposits - restricted | ||||||
| Available-for-sale securities | ||||||
| Securities at fair value through profit or loss | ||||||
| Securities purchased under agreements to resell | ||||||
| Accrued investment income | ||||||
| Premiums receivable | ||||||
| Reinsurance assets | ||||||
| Other assets | ||||||
| Deferred tax assets | ||||||
| Cash and cash equivalents | ||||||
| Total assets | ||||||
| LIABILITIES AND EQUITY | ||||||
| Liabilities | ||||||
| Insurance contracts | ||||||
| Investment contracts | ||||||
| Policyholder dividends payable | ||||||
| Interest-bearing loans and borrowings | ||||||
| Lease liabilities | ||||||
| Bonds payable | ||||||
| Financial liabilities at fair value through profit or loss | ||||||
| Securities sold under agreements to repurchase | ||||||
| Annuity and other insurance balances payable | ||||||
| Premiums received in advance | ||||||
| Other liabilities | ||||||
| Deferred tax liabilities | ||||||
| Current income tax liabilities | ||||||
| Statutory insurance fund | ||||||
| Total liabilities | ||||||
| Equity | ||||||
| Share capital | ||||||
| Reserves | ||||||
| Retained earnings | ||||||
| Attributable to equity holders of the Company | ||||||
| Non-controlling interests | ||||||
| Total equity | ||||||
| Total liabilities and equity | ||||||
Loading...
